gptkbp:instanceOf
|
patent
|
gptkbp:abstract
|
The invention relates to a method for treating cancer using a specific compound.
|
gptkbp:applicationNumber
|
10/780,093
|
gptkbp:applicationType
|
non-provisional
|
gptkbp:assignee
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:citedBy
|
gptkb:US_7,123,456
|
gptkbp:claims
|
20
|
gptkbp:clinicalTrials
|
NCT01234567
|
gptkbp:coInventor
|
Jane_Smith
|
gptkbp:collaborations
|
gptkb:ABC_Corp.
|
gptkbp:country
|
gptkb:United_States
|
gptkbp:examinationType
|
regular
|
gptkbp:expirationDate
|
2024-02-06
|
gptkbp:fieldOfUse
|
oncology
|
gptkbp:filingDate
|
2004-02-06
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,093 C31
|
gptkbp:internationalClassification
|
A61K
|
gptkbp:inventiveStep
|
novel compound
|
gptkbp:inventor
|
gptkb:John_Doe
|
gptkbp:issueDate
|
2004-09-14
|
gptkbp:legalStatus
|
granted
|
gptkbp:maintenanceFee
|
paid
|
gptkbp:marketedAs
|
Drug Y
|
gptkbp:material
|
compound X
|
gptkbp:patentAbstract
|
available.
ongoing.
strong.
significant.
positive.
biotechnology.
multiple.
peer-reviewed.
commercial stage.
oncology.
new treatment method.
The invention provides a method for treating cancer.
|
gptkbp:patentCitation
|
none.
ongoing.
with universities.
significant.
high.
expanding.
promising.
addressed.
increasing.
launched.
funded.
cancer treatment.
improved patient outcomes.
pharmaceutical market.
US_5,678,901
|
gptkbp:patentDescription
|
Detailed description of the invention.
Phase II.
|
gptkbp:patentExpiration
|
2024-02-06
|
gptkbp:patentFamily
|
US_6,789,093_family
|
gptkbp:patentField
|
medical treatment.
|
gptkbp:patentFilingDate
|
2004-09-14
|
gptkbp:patentImage
|
image_url_here
|
gptkbp:patentInventor
|
protected.
XYZ Pharma.
|
gptkbp:patentLink
|
link_to_patent
|
gptkbp:patentLitigation
|
none
|
gptkbp:patentMaintenanceFee
|
5 years
notable.
therapeutic.
|
gptkbp:patentNumber
|
6,789,093
|
gptkbp:patentOwner
|
gptkb:Bristol-Myers_Squibb_Company
|
gptkbp:patentStatus
|
filed
broad.
assignment.
|
gptkbp:patentType
|
utility
Utility patent for a method.
approved.
therapeutic innovation.
FDA_approved.
|
gptkbp:priorityDate
|
2003-02-06
|
gptkbp:relatedPatent
|
gptkb:US_6,789,094
|
gptkbp:relatedTo
|
gptkb:US_6,123,456
|
gptkbp:releasedIn
|
full
|
gptkbp:research_areas
|
anti-cancer
|
gptkbp:researchField
|
pharmaceuticals
|
gptkbp:researchInterest
|
gptkb:XYZ_University
|
gptkbp:status
|
active
|
gptkbp:title
|
Method for treating cancer
|